Samir Kaul - 14 Jun 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Jun 2023, 18:08:44 UTC
Prior SEC filing
24 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John J. Demeter, as attorney-in-fact for Samir Kaul

Key filing fact

Samir Kaul filed Form 4 for Guardant Health, Inc. (GH) on 16 Jun 2023.

Key facts

  • This page summarizes Samir Kaul's Form 4 filing for Guardant Health, Inc. (GH).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2023, 18:08.

Change

  • Previous filing in this sequence was filed on 24 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

COMMON STOCK

Options Exercise

Transaction value
$0
Shares
+5,531
Change %
+94%
Price
$0.000000
Shares after
11,404
Date
14 Jun 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

RESTRICTED STOCK UNITS

Options Exercise

Transaction value
$0
Shares
-5,531
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Jun 2023
Ownership
Direct
Underlying class
COMMON STOCK
Underlying amount
5,531
Exercise price
$0.000000
Footnotes
F1, F2
GH transaction Derivative

STOCK OPTION (RIGHT TO BUY)

Award

Transaction value
$0
Shares
+8,803
Change %
Price
$0.000000
Shares after
8,803
Date
14 Jun 2023
Ownership
Direct
Underlying class
COMMON STOCK
Underlying amount
8,803
Exercise price
$38.00
Footnotes
F3
GH transaction Derivative

RESTRICTED STOCK UNITS

Award

Transaction value
$0
Shares
+5,592
Change %
Price
$0.000000
Shares after
5,592
Date
14 Jun 2023
Ownership
Direct
Underlying class
COMMON STOCK
Underlying amount
5,592
Exercise price
$0.000000
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.

Footnote F2

Not applicable for Restricted Stock Units.

Footnote F3

The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.

Footnote F4

The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .